CSIMarket Company Name, Ticker, Suppliers, else..
 
Innovation Pharmaceuticals Inc   (CTIX)
Other Ticker:  
 
 

Innovation Pharmaceuticals Inc Balance Sheet Annual

CTIX


Select the Financial Report:   Period:   Fiscal Year:




New: More CTIX's historic Annual Balance Sheets >>

CTIX Balance Sheets
(Annual, GAAP in millions $)

 (Jun 30 2023)
2023		 (Jun 30 2022)
2022		 (Jun 30 2021)
2021		 (Jun 30 2020)
2020		 (Jun 30 2019)
2019
ASSETS
Cash & cash equivalent 1.52 3.81 10.19 6.02 0.58
Security Deposit 0.08 0.08 0.08 0.08 0.08
Cash & Short-term Investments 1.60 3.89 10.27 6.10 0.66
Accounts receivable - - - - -
Other Receivables - - - - -
Notes Receivable, Current - - - - -
Inventories - - - - -
Deferred Costs, Current AS - 0.06 0.78 - -
Prepaid Expense And Other Assets Current 0.12 0.15 0.50 0.09 0.05
Total Current Assets 1.71 4.09 11.55 6.19 0.70
Equipment/Property/Plant Net - - - - 0.00
Goodwill net - - - - -
Intangible Assets - 2.31 2.75 3.06 -
Long-term investments 3.81 3.98 - - -
Accounts Receivable, Net, Noncurrent - - - - -
Financial Instruments - - - - -
Tax Assets, Noncurrent - - - - -
Other Assets, Noncurrent 1.00 - - - 3.34
Deferred, Prepaid and Other Assets, Noncurrent - - - - -
Discontinued operations, Noncurrent - - - - -
Patents Net 2.00 - - - -
Patents Net 2.00 - - - -
Total Assets 7.52 10.38 14.30 9.25 4.05
LIABILITIES
Accounts Payable, Current AC 2.99 2.57 2.56 2.04 -
Accrued Liabilities, Current AC 0.07 0.09 0.35 0.06 0.09
Derivative Liability, Current DE - - - - -
Convertible Notes Payable, Current NO 0.21 - 0.17 0.08 -
Other Liabilities, Current 1.75 2.15 3.46 5.19 7.21
Taxes Payable - - - - -
Deferred Liability and Revenue - - - - -
Discontinued Operation, Liabilities, Current - - - - -
OperatingLeaseLiabilityNoncurrent - 0.06 0.25 0.42 -
Accrued Dividend Series B Five Convertibles Preferred Stock - 0.06 0.17 0.14 -
Operating Lease Liability Current 0.06 0.20 - - -
Total Current Liabilities 5.02 4.81 6.54 7.37 7.30
Long-term debt - - - - -
Capital Lease and Other - - - - -
Convertible Notes Payable NO - - - - -
Total Long-term Debt - - - - -
Financial Instruments, Insurance, Noncurrent - - - - -
Employee Benefit Plans, Noncurrent - - - - -
Deferred credits, Noncurrent - - - - -
Deferred Tax Liabilities, Deferred Expense, Capitalized Patent Costs - - - - 3.34
Discontinued Operation, Liabilities, Noncurrent - - - - -
Other liabilities, Noncurrent 0.46 0.84 0.25 0.42 -
Total Liabilities 5.48 5.65 6.79 7.79 8.18
SHAREHOLDER'S EQUITY
Common Stock Value 0.05 0.05 0.04 0.03 0.02
Treasury Stock Value -2.25 -2.25 -2.25 -0.15 -0.09
Additional Paid In Capital Common Stock 129.57 129.09 124.84 102.82 90.54
Retained Earnings / Accumulated Deficit -125.33 -122.16 -115.12 -101.24 -94.60
Other Equity 0.00 0.00 0.00 0.00 0.00
Noncontrolling interests & other - - - - -
Total Stockholder's Equity 2.04 4.73 7.51 1.46 -4.13
Liabilities & Stockholder's Equity 7.52 10.38 14.30 9.25 4.05






Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com